Related Experiment Video
Updated: Feb 16, 2026

Isolation of CD133+ Liver Stem Cells for Clonal Expansion
Published on: October 10, 2011
Cancer cell reprogramming to identify the genes competent for generating liver cancer stem cells
Kenly Wuputra1, Chang-Shen Lin1,2, Ming-Ho Tsai1
1Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, 807 Taiwan.
Abstract:
The cancer stem cell (CSC) hypothesis postulates that cancer originates from the malignant transformation of stem/progenitor cells and is considered to apply to many cancers, including liver cancer. Identification that CSCs are responsible for drug resistance, metastasis, and secondary tumor appearance suggests that these populations are novel obligatory targets for the treatment of cancer. Here, we describe our new method for identifying potential CSC candidates. The reprogramming of cancer cells via induced pluripotent stem cell (iPSC) technology is a novel therapy for the treatment and for the study of CSC-related genes. This technology has advantages for studying the interactions between CSC-related genes and the cancer niche microenvironment. This technology may also provide a useful platform for studying the genes involved in the generation of CSCs before and after reprogramming, and for elucidating the mechanisms underlying cancer initiation and progression. The present review summarizes the current understanding of transcription factors involved in the generation of liver CSCs from liver cancer cell-derived iPSCs and how these contribute to oncogenesis, and discusses the modeling of liver cancer development.
Insights
Cancer stem cells (CSCs) drive liver cancer progression and drug resistance. Induced pluripotent stem cell (iPSC) technology offers a new way to study liver CSCs and develop targeted cancer therapies.
Area of Science:
- Oncology
- Stem Cell Biology
- Cancer Research
Background:
- The cancer stem cell (CSC) hypothesis suggests that cancers, including liver cancer, originate from transformed stem/progenitor cells.
- CSCs are implicated in cancer's drug resistance, metastasis, and recurrence, making them critical therapeutic targets.
Purpose of the Study:
- To introduce a novel method for identifying potential liver cancer stem cell (CSC) candidates.
- To explore the utility of induced pluripotent stem cell (iPSC) technology for studying CSCs and developing new cancer treatments.
Main Methods:
- Utilizing induced pluripotent stem cell (iPSC) technology to reprogram cancer cells.
- Investigating the interactions between CSC-related genes and the tumor microenvironment.
- Analyzing transcription factors involved in generating liver CSCs from iPSCs.
Main Results:
- iPSC technology provides a valuable platform for studying CSC generation and cancer initiation mechanisms.
- The reprogramming process allows for the examination of CSC-related genes before and after iPSC generation.
- This approach facilitates the study of liver CSCs and their role in oncogenesis.
Conclusions:
- Targeting CSCs is essential for effective liver cancer treatment.
- iPSC technology is a promising tool for understanding liver CSCs and developing novel therapeutic strategies.
- Further research into transcription factors and microenvironmental interactions is crucial for modeling liver cancer development.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Somatic to iPS Cell Reprogramming
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Methods of Nuclear Reprogramming

